Why Your Sitagliptin May Not Be Working as Hard as It Should: The Sleep Apnea Connection

When the Numbers Don't Add Up

You take your sitagliptin every morning without fail. You've made meaningful changes to your diet. You walk regularly and try to manage stress. Yet your A1C remains higher than your care team would like, and your fasting glucose readings continue to surprise you. If this scenario sounds familiar, it may be worth asking a question that rarely comes up in a standard diabetes appointment: How well are you sleeping?

For millions of Americans living with type 2 diabetes, obstructive sleep apnea is an undetected companion — one that quietly undermines blood sugar regulation night after night. Research consistently shows that the two conditions co-occur at striking rates, yet sleep apnea screening remains far from routine in most diabetes care settings. The result is a treatment gap that leaves patients frustrated and, in many cases, exposed to accelerating metabolic harm.

What Sleep Apnea Actually Does to Your Metabolism

Obstructive sleep apnea occurs when the airway repeatedly collapses during sleep, causing brief but frequent interruptions in breathing. Each episode triggers a stress response in the body — a small but real surge of cortisol and adrenaline that jolts the system back into breathing. Over the course of a single night, this can happen dozens or even hundreds of times.

Those stress hormone surges have direct metabolic consequences. Cortisol is well known for its glucose-raising effects; it signals the liver to release stored sugar into the bloodstream and simultaneously promotes insulin resistance in muscle and fat tissue. For someone without diabetes, this physiological stress response is manageable. For someone with type 2 diabetes, it represents a recurring overnight assault on blood sugar stability.

Beyond cortisol, fragmented sleep disrupts the normal release of growth hormone, impairs the sensitivity of cells to insulin, and promotes systemic inflammation — all of which compound the challenge of glucose control. When sitagliptin works by enhancing the body's natural incretin response to meals, it operates within a system that sleep deprivation has already compromised. The medication is doing its job, but the metabolic environment has been quietly shifted against it.

The Overlap Is Not a Coincidence

Studies published in peer-reviewed endocrinology and sleep medicine journals have documented a substantial overlap between obstructive sleep apnea and type 2 diabetes. Estimates suggest that between 50 and 70 percent of people with type 2 diabetes may have some degree of sleep apnea, though many remain undiagnosed. Conversely, people with sleep apnea face a significantly elevated risk of developing insulin resistance and eventually type 2 diabetes.

The relationship is bidirectional and self-reinforcing. Excess weight — a common feature of both conditions — narrows the airway and worsens apnea severity. Poor sleep promotes weight gain by elevating hunger hormones and reducing the motivation to exercise. And elevated blood sugar, in turn, can damage the nerves and blood vessels that regulate breathing during sleep. Each condition feeds the other in ways that are difficult to untangle without addressing both simultaneously.

Recognizing the Warning Signs

Many people with obstructive sleep apnea are unaware they have it, in part because the most obvious symptom — breathing pauses — occurs while they are asleep. Partners or roommates may notice loud snoring, gasping, or choking sounds, but people who sleep alone may have no external observer to flag the problem.

Symptoms worth discussing with your physician include:

• Persistent daytime fatigue or drowsiness, even after what feels like a full night's sleep
• Morning headaches, which can result from overnight drops in blood oxygen
• Difficulty concentrating or memory lapses during the day
• Waking with a dry mouth or sore throat
• Frequent nighttime urination, which can sometimes be triggered by the pressure changes associated with apnea events
• Unexplained mood changes, including irritability or low-grade depression

If several of these sound familiar alongside blood sugar readings that don't respond as expected to your current medication regimen, raising the possibility of sleep apnea with your care team is a reasonable and potentially important step.

Bringing Sleep Into Your Diabetes Conversation

Despite the strength of the evidence linking sleep apnea to metabolic dysfunction, sleep health is often treated as a separate domain from diabetes management. Endocrinologists and primary care physicians may not routinely screen for sleep disorders, and sleep specialists may not always be aware of a patient's diabetes status. Bridging that gap requires some initiative on the part of the patient.

When speaking with your physician, consider framing the conversation around unexplained glycemic variability. If your medication adherence is consistent and your lifestyle habits are reasonable but your numbers remain unpredictable, that inconsistency itself is a clinical signal worth investigating. Asking for a referral to a sleep specialist or requesting a home sleep apnea test — which is now widely available and covered by most major insurance plans — is a straightforward starting point.

The diagnostic process has become considerably less burdensome than it once was. While formal polysomnography (an overnight study conducted in a sleep lab) remains the gold standard, home-based sleep studies are now accepted as appropriate for diagnosing obstructive sleep apnea in many patients. Results are typically available within a week, and if apnea is confirmed, treatment options can be discussed promptly.

How Treatment May Improve Medication Response

The most commonly prescribed treatment for obstructive sleep apnea is continuous positive airway pressure therapy, better known as CPAP. A CPAP machine delivers a steady stream of pressurized air through a mask worn during sleep, preventing the airway from collapsing and eliminating the breathing interruptions that drive the overnight stress response.

Multiple clinical studies have examined what happens to blood sugar control when sleep apnea is treated in people with type 2 diabetes. The results, while variable, are encouraging. Several trials have documented improvements in insulin sensitivity and modest reductions in fasting glucose among patients who adhere consistently to CPAP therapy. The effect appears most pronounced in individuals with more severe apnea and in those who use their CPAP device for the recommended minimum of four to five hours per night.

For patients on sitagliptin specifically, addressing sleep apnea may allow the medication to function within a more stable hormonal environment — one where cortisol surges are reduced, insulin sensitivity is less impaired overnight, and the body's incretin system is not constantly working against a backdrop of systemic inflammation.

A More Complete Approach to Diabetes Management

Effective diabetes care has never been purely about medication. It encompasses nutrition, physical activity, stress management, and — as the evidence increasingly makes clear — sleep quality. Sitagliptin is a well-established, carefully studied therapy with a strong safety profile, but no medication performs optimally when the body's broader physiological systems are under sustained stress.

If you are managing type 2 diabetes and have not been screened for sleep apnea, it is worth having that conversation with your physician. The evaluation is non-invasive, widely accessible, and could reveal a treatable condition that has been quietly limiting your progress. In diabetes management, as in most areas of medicine, what you don't know can matter just as much as what you do.